Brilacidin Brilacidin by Innovation Pharmaceut

Brilacidin

Brilacidin by Innovation Pharmaceuticals is a candidate being evaluated as a potential treatment for coronavirus. Brilacidin has shown antibacterial, anti-inflammatory and immunomodulatory properties in several clinical trials.156 Review articles suggest that immunomodulators, like Brilacidin could potentially act synergistically when combined with antivirals.157,158

https://sph.nus.edu.sg/wp-content/uploads/202...13-Apr.pdf


Updated April 8th

Brilacidin by Innovation Pharmaceuticals

Innovation Pharmaceuticals announced that it is evaluating Brilacidin, a defensin mimetic drug candidate, as a potential treatment for coronavirus. Brilacidin has shown antibacterial, anti-inflammatory and immunomodulatory properties in several clinical trials.

The company is planning to explore research collaborations and seek federal grants to develop the coronavirus drug. It is already investigating the drug for inflammatory bowel disease and oral mucositis in cancer patients.

Innovation has signed two material transfer agreements with a university in the US and 12 biocontainment labs in the US for evaluation of Brilacidin as a treatment for COVID-19. One of the biocontainment labs is scheduled to commence testing of the drug in the third week of March.

https://vietnamtimes.org.vn/top-coronavirus-d...19264.html


Was going to put this on the COVID board but I ONLY posted the Brilacidin excerpts!!

Maybe I'm a bit biased??


Many of these site want you to register to leave a reply to be able to post replies to give updates in their comment sections. I get enough spam as it is. But you can e-mail the authors easy enough.